PT  - JOURNAL ARTICLE
AU  - Junko Kurita
AU  - Tamie Sugawara
AU  - Yasushi Ohkusa
TI  - Effectiveness of COCOA, a COVID-19 contact notification application, in Japan
AID  - 10.1101/2020.07.11.20151597
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.11.20151597
4099  - http://medrxiv.org/content/early/2020/07/14/2020.07.11.20151597.short
4100  - http://medrxiv.org/content/early/2020/07/14/2020.07.11.20151597.full
AB  - Background COCOA, a contact reporting application in Japan, was launched at the end of June 2020.Object We assessed effectiveness of COCOA.Method After developing a simple susceptible–infected–recovery model with COCOA and voluntary restrictions against going out (VRG), we assumed that COCOA can reduce infectiousness by 10–50% points through self-quarantine at home after receiving notification from COCOA.Results COCOA alone is insufficient to halt an outbreak. Even if the entire population were to use COCOA, the reproduction number would be 1.31. However, if VRG were 15%, about half of the maximum VRG effectiveness under the emergency state declaration, then 10% COCOA use by a population can reduce the reproduction number to less than one.Conclusion Significant effects of COCOA for reducing the reproduction number were found. However, without VRG, COCOA alone is insufficient to control an outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All information used for this study has been published. There is therefore no ethical issue related to this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases. https://www.mhlw.go.jp/stf/newpage_10723.html